Literature DB >> 32232568

Ocular manifestation, eye protection, and COVID-19.

Rujittika Mungmungpuntipantip1, Viroj Wiwanitkit2,3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32232568      PMCID: PMC7104709          DOI: 10.1007/s00417-020-04662-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
Dear Editor, We found that the report on “Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong” is very interesting [1]. Lai et al. noted that “In order to minimise transmission of COVID-19, ophthalmologists should work closely with local infection control teams to implement infection control measures that are appropriate for their own clinical settings [1].” In fact, Li et al. pointed out the possibility of ocular manifestation in COVID-19 and the importance of eyewear [2]. We would like to share ideas and experience from Thailand, the second country in Southeast that the new infection-19 has been occurred for 3 months [3]. At present (March 6, 2020), there are accumulated 48 COVID-19 patients. From these 48 cases, the complete physical examination including the eye examination, which includes direct ophthalmoscopy and further corneal scraping in suspicious conjunctivitis case, to detect ocular manifestation was done in each case, and there is no report on ocular problem. Nevertheless, it should note that the ocular manifestation is usually overlooked by Thai practitioners. The local infection control guidelines provided by local medical professor team state for only fever and respiratory manifestation (local guideline by the Department of Medical Services, Ministry of Public Health is available online at https://www.dms.moph.go.th/backend//Content/Content_File/Practice_guidelines/Attach/25630213145852PM_2019-nCoV_flow_HosManage_Feb5.pdf). It is no doubt that the case with initial presentation of eye problem is easily missed. In addition, there has never recommendation for eyewear use in medical practice. Practitioner usually wears facemask and exposes eyes to the patient. Modification of the present infection control guidelines to include the eye protective device during medical practice is suggested. It is necessary to educate the practitioner for recognizing possible ocular manifestation of COVID-19.
  2 in total

1.  Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear.

Authors:  Ji-Peng Olivia Li; Dennis Shun Chiu Lam; Youxin Chen; Daniel Shu Wei Ting
Journal:  Br J Ophthalmol       Date:  2020-03       Impact factor: 4.638

2.  Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong.

Authors:  Tracy H T Lai; Emily W H Tang; Sandy K Y Chau; Kitty S C Fung; Kenneth K W Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-03       Impact factor: 3.535

  2 in total
  16 in total

1.  COVID-19 in Ophthalmology. Current Disease Status and Challenges during Clinical Practice.

Authors:  Georgios Bontzos; Anastasia Gkiala; Christina Karakosta; Neofytos Maliotis; Efstathios T Detorakis
Journal:  Maedica (Bucur)       Date:  2021-12

2.  Infectious rate of ocular discharges in patients with approved COVID-19 respiratory infection.

Authors:  Behzad Davarnia; Habib Ojaghi; Farhad Jeddi; Masood Bagheri; Amin Najafi
Journal:  J Family Med Prim Care       Date:  2022-05-14

Review 3.  Unfolding COVID-19: Lessons-in-Learning in Ophthalmology.

Authors:  Ranju Kharel Sitaula; Anadi Khatri; M K Janani; Rajendra Mandage; Soumen Sadhu; H N Madhavan; Madan Prasad Upadhyay; Jyotirmay Biswas
Journal:  Clin Ophthalmol       Date:  2020-09-28

4.  Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.

Authors:  Francesco Aiello; Gabriele Gallo Afflitto; Raffaele Mancino; Ji-Peng Olivia Li; Massimo Cesareo; Clarissa Giannini; Carlo Nucci
Journal:  Eye (Lond)       Date:  2020-05-18       Impact factor: 4.456

5.  COVID-19 Pandemic and Ophthalmologists

Authors:  Joob Beuy; Viroj Wiwanitkit
Journal:  Turk J Ophthalmol       Date:  2020-06-27

6.  Reply to ocular manifestation, eye protection, and COVID-19.

Authors:  Tracy H T Lai; Emily W H Tang; Sandy K Y Chau; Kenneth K W Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-04-01       Impact factor: 3.117

7.  Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

Authors:  Kanika Aggarwal; Aniruddha Agarwal; Nishant Jaiswal; Neha Dahiya; Alka Ahuja; Sarakshi Mahajan; Louis Tong; Mona Duggal; Meenu Singh; Rupesh Agrawal; Vishali Gupta
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

Review 8.  Human coronaviruses: ophthalmic manifestations.

Authors:  Mohd-Asyraaf Abdul-Kadir; Lik Thai Lim
Journal:  BMJ Open Ophthalmol       Date:  2020-11-02

9.  Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study.

Authors:  Mojtaba Abrishami; Zahra Emamverdian; Naser Shoeibi; Arash Omidtabrizi; Ramin Daneshvar; Talieh Saeidi Rezvani; Neda Saeedian; Saeid Eslami; Mehdi Mazloumi; SriniVas Sadda; David Sarraf
Journal:  Can J Ophthalmol       Date:  2020-11-14       Impact factor: 1.882

10.  Ocular transmission and manifestation for coronavirus disease: a systematic review.

Authors:  Ahmed Almazroa; Suhailah Alamri; Balsam Alabdulkader; Hanan Alkozi; Altaf Khan; Walead Alghamdi
Journal:  Int Health       Date:  2022-03-02       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.